| Item | Cat. No. | Type | Clone No |
| Anti-PDCD1/CD279/PD1 mAbs [Retifanlimab Biosimilar] (MABL-5162) | MABL-5162 | ELISA, FACS, Functional assay, in vivo binding | G4, Kappa |
| Anti-PDL1/CD274 mAbs [Retlirafusp Biosimilar] (MABL-5163) | MABL-5163 | ELISA, FACS, Functional assay, in vivo binding | G4, Kappa |
| Anti-TNFRSF4/CD134/OX40 mAbs [Revdofilimab Biosimilar] (MABL-5164) | MABL-5164 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-CD3;SIGLEC2/CD22 mAbs [Rezetamig Biosimilar] (MABL-5165) | MABL-5165 | ELISA, FACS, Functional assay, in vivo binding | G4;G4, Kappa;Kappa |
| Anti-KLRB1 mAbs [Rezorstobart Biosimilar] (MABL-5166) | MABL-5166 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-C1S mAbs [Riliprubart Biosimilar] (MABL-5167) | MABL-5167 | ELISA, FACS, Functional assay, in vivo binding | G4, Kappa |
| Anti-GDF15/MIC1/MIC-1/NAG1/NAG-1/PTGFB mAbs [Rilogrotug Biosimilar] (MABL-5168) | MABL-5168 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-HGF/SF mAbs [Rilotumumab Biosimilar] (MABL-5169) | MABL-5169 | ELISA, FACS, Functional assay, in vivo binding | G2, Kappa |
| Anti-IL31 (Canine) mAbs [Riltovetbart Biosimilar] (MABL-5170) | MABL-5170 | ELISA, FACS, Functional assay, in vivo binding | G2, Kappa |
| Anti-KDR/CD309/VEGFR2 mAbs [Ramucirumab Biosimilar] (MABL-5141) | MABL-5141 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-NGFB mAbs [Ranevetmab Biosimilar] (MABL-5142) | MABL-5142 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-VEGFA mAbs [Ranibizumab Biosimilar] (MABL-5143) | MABL-5143 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-KARS1 mAbs [Rapaprutug Biosimilar] (MABL-5144) | MABL-5144 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-TNFRSF5/CD40 mAbs [Ravagalimab Biosimilar] (MABL-5145) | MABL-5145 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-C5 mAbs [Ravulizumab Biosimilar] (MABL-5146) | MABL-5146 | ELISA, FACS, Functional assay, in vivo binding | G2, Kappa |
| Anti-PCSK9 mAbs [Recaticimab Biosimilar] (MABL-5147) | MABL-5147 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-IL1RL2/IL1Rrp2/IL1RRP2/IL-36R/IL36R mAbs [Recibokibart Biosimilar] (MABL-5148) | MABL-5148 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-SIGLEC4/MAG mAbs [Refanezumab Biosimilar] (MABL-5149) | MABL-5149 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-VEGFB mAbs [Reflocibart Biosimilar] (MABL-5150) | MABL-5150 | ELISA, FACS, Functional assay, in vivo binding | G4, Kappa |
| Anti-SARS-CoV-2 Spike RBD mAbs [Regdanvimab Biosimilar] (MABL-5151) | MABL-5151 | ELISA, FACS, Functional assay, in vivo binding | G1, Lambda |
联系我们
Copyright © 2012-2029 西安迈博睿(Mabioway)生物科技有限公司 版权所有
地址:陕西省西安市浐灞生态区广运潭大道南段4555号长安大学科技园4号楼A单元2层
电话:15339069646 邮箱:info@mabioway.cn
